Both in Biotechnology
Elutia vs Aligos Therapeutics
Over the past year ELUT returned −15.2% and ALGS returned −41.6%; their daily moves had a correlation of 0.12.
ELUT −15.2% ALGS −41.6%Growth of $1, one year, split-adjusted
| Metric | ELUT | ALGS |
|---|---|---|
| Price | $0.7890 | $5.62 |
| Market cap | $34.9M | $35.1M |
| Today | −2.59% | +1.44% |
| 1 month | −10.3% | −18.7% |
| 6 months | −24.9% | −14.3% |
| Year to date | +13.9% | −39.7% |
| 1 year | −20.5% | −42.6% |
| Revenue growth (YoY) | −11.6% | +2778.5% |
| Gross margin | 59.6% | 100.0% |
| Net margin | −315.0% | −5.4% |
| P/E (TTM) | 0.7× | — |
| Price / sales | 2.9× | 1.1× |
| Net cash | $19.9M | $30.3M |
| Dividend yield | — | — |
| Volatility (60d) | 56.8% | 104.4% |
| Short % of float | 0.0% | 14.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).